Type 2 diabetes mellitus. diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: Grape seed extract, grape seed extract 263.2 mg, two tablets daily, duration of use 30 days, Shari Pharmaceutical Supplement Company. All patients are asked to cont
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
25 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age 25_80 years HbA1C 7%_8/5% FBS 126_200 mg/dl Diabetes diagnosis period less than 10 years Patients use only oral hypoglycemic drugs BMI less than 35
Exclusion criteria
Exclusion criteria: Breastfeeding_ pregnancy Insulin therapy Obvious renal and hepatic insufficiency { Obvious renal failure with CLCr less than 30 and obvious hepatic insufficiency with ALT or AST more than 100 }
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TG. Timepoint: At the beginning of the intervention and 30 days after taking Grape seed. Method of measurement: Blood test.;Cholesterol. Timepoint: At the beginning of the intervention and 30 days after taking Grape seed. Method of measurement: Blood test.;HDL. Timepoint: At the beginning of the intervention and 30 days after taking Grape seed. Method of measurement: Blood test.;LDL. Timepoint: At the beginning of the intervention and 30 days after taking Grape seed. Method of measurement: Blood test.;FBS. Timepoint: At the beginning of the intervention and 30 days after taking Grape seed. Method of measurement: Blood test.;Systolic blood pressure. Timepoint: At the beginning of the intervention and 30 days after taking Grape seed. Method of measurement: Sphygmomanometer.;Diastolic blood pressure. Timepoint: At the beginning of the intervention and 30 days after taking Grape seed. Method of measurement: Sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrnoosh Zakerkish
Ahvaz University of Medical Sciences
Outcome results
None listed